Kourtney G. Gardner, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2724 Nashville Rd, Bowling Green, KY 42101 Phone: 270-780-0560 Fax: 270-780-0467 |
Dr. Jonathon Baldwin, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1724 Rockingham Ave, Suite 101, Bowling Green, KY 42104 Phone: 270-842-7588 Fax: 270-842-7687 |
Dr. Thomas G. Sternberg, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2724 Nashville Rd, Bowling Green, KY 42101 Phone: 270-780-0560 Fax: 270-780-0467 |
James R Parkerson, D.O. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2724 Nashville Rd, Bowling Green, KY 42101 Phone: 270-780-0560 Fax: 270-780-0467 |
Dr. Patricia Mercer, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2724 Nashville Rd, Bowling Green, KY 42101 Phone: 270-780-0560 Fax: 270-780-0467 |
Dr. Diana K Cavanah, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 201 Park St, Bowling Green, KY 42101 Phone: 270-781-5111 Fax: 270-780-0467 |
Dr. Indar Mohan Jhamb, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1217 Ashley Cir, Bowling Green, KY 42104 Phone: 270-782-3237 Fax: 270-782-1412 |
News Archive
Repligen Corporation today announced that the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee will meet on May 31, 2012 to discuss the Company's New Drug Application (NDA) for SecreFlo for the improved detection of pancreatic duct abnormalities in combination with magnetic resonance imaging (MRI) in patients with pancreatitis.
C-reactive protein (CRP), a biomarker for inflammation in the blood, can help to identify individuals whose abnormal precancerous lesions will advance closer to invasive lung cancer.
The New England Journal of Medicine study is the first independent assessment of guidelines released last fall on the use of the heart medications and it shows 56 million people between the ages of 40 and 75 are eligible for the treatment.
A groundbreaking law, the California Cruelty-Free Cosmetics Act, which passed in 2018, will ban all sales of cosmetics that have been tested on animals after January 1, 2020.
Leveraging Israel's experience in dealing with crises on a daily basis, Ben-Gurion University of the Negev researcher, Dr. Zvi Reich, has launched a new online tool to help and evaluate and improve crisis preparedness and emergency communications.
› Verified 3 days ago